Contributed by:

PharmaVOICE Staff

NOTE: The content below contains the first few paragraphs of the printed article and the titles of the sidebars and boxes, if applicable.

PV0915_LillyDisneyLilly Launches Disney Book for Children Affected by Diabetes

Lilly Diabetes has expanded its collection of resources for families of children with type 1 diabetes with the publication of Go, Team Coco! The story is the fourth Disney book in a series featuring Coco, a charismatic and fun-loving monkey who has type 1 diabetes. The book will be available immediately from most pediatric endocrinologists’ offices in the United States.

This latest Team Coco book for young children in the Lilly Diabetes/Disney collection also includes Coco and Goofy’s Goofy Day, Coco Goes Back to School, and Coco’s First Sleepover. A series of chapter books for older children is also available. All the books are available free of charge through pediatric endocrinologists’ offices, and most are also accessible digitally at T1EverydayMagic.com.

FDA Approves First 3D-Printed Drug

The FDA has approved Aprecia Pharmaceuticals’ Spritam to treat seizures in adults and children with epilepsy. The product uses the company’s ZipDose technology, which uses 3D-printing to produce a porous formulation that rapidly disintegrates with a sip of liquid.

“By combining 3D printing technology with a highly-prescribed epilepsy treatment, Spritam is designed to fill a need forPV0915_MostReputable patients who struggle with their current medication experience,” says Don Wetherhold, CEO of Aprecia.

See the Innovator’s issue, March 2015 issue, of PharmaVOICE for more information about Aprecia and the technology.

Americans Face High Drug Costs

The number of U.S. patients estimated to have annual medication costs greater than $50,000 jumped 63% between 2013 and 2014, from 352,000 to 576,000 Americans, according to a recent report by Express Scripts. The population of patients estimated to be taking at least $100,000 worth of medication nearly tripled in the same time period, from 47,000 to 139,000 Americans.The majority of these patients take at least 10 medications, from at least four different prescribers. Baby boomers, ages 51-70, surpassed all other age groups as the highest-cost medication users, making up 58% of the population with annual drug costs exceeding $100,000.

Roche Fosters Innovation

Roche welcomed 100 European university students from 34 countries studying science and art to the Salzburg Festival, the PV0915_PharmaPipelineworld’s largest and most prestigious festival of music and drama. The annual Roche Continents week offers highly talented undergraduate and graduate students the opportunity to explore sources of inspiration at the intersection of science and music through structured workshops and challenges.

This year, students examined the common ground of creativity across the scientific and artistic fields under the instruction of accomplished music composers, photographers, musicians, and scientists of quantum physics, molecular biology, and medicinal chemistry. Roche Continents is a unique chance to learn about music as well as the creative processes within arts and science that drive innovation.

“Creativity in music, arts, and science has a lot in common,” says Christoph Franz, Roche’s chairman of the board of directors. “It needs people who are passionate, brave, and who are ready to travel unknown paths. No matter what profession we ultimately pursue in life, it is essential to know what motivates us to follow our passions.”(PV)


PV0915_AwardsOgilvy HealthPR Wins Two Awards
Ogilvy HealthPR achieved double honors at this year’s Communiqué Awards. The agency received an award in the category of Excellence in Digital Communications — Prescription Products/Patient Health and was Highly Commended in the Excellence in Corporate Communications category.

Upcoming Webinar:
Script Abandonment: Untangling Influences Across the Patient Journey
September 17, 2015
Sponsored by: Zitter Health Insights

Creating Customer Engagement and Action Through Experiential Marketing
Provided by: PulseCX

Blinding of Investigational Products —
Part of the Clinical Supply Knowledge
Share Series
Provided by: Almac

White Papers:
From Hospital to Home: The Changing Therapeutic Area of Oncology
Provided by: Atlantis Healthcare

Data Capture via Mobile Electronic Clinical Outcome Assessments (eCOA)
Provided by: Exco InTouch

4 Ways Pharma Can Build Trust and Loyalty: Patient Connections and Shared Values —
A How-To Guide
Provided by: Health Perspectives Group

The Impact and Use of Social Media in PharmacovigilancePV0915_PatientsNotAware
Provided by: Sciformix

CoPay with Proof
Provided by: TrialCard

Leveraging Patient Feedback Data to Support Effectiveness and Demonstrate Outcomes
Provided by: TrialCard

Five Best Practices to Deliver Exceptional Multichannel Experiences
Provided by: Veeva Systems

4 Ways Pharma Can Build Trust and Loyalty: Patient Connections and Shared Values – A Panel Discussion
Sponsored by: Health Perspectives Group

Specialized Online Medical Communities: Uncover Insights and Engage Targeted HCP Audiences
Sponsored by: Skipta

Putting Volunteers First: What Every Clinical Team Should Consider Before Developing the Next Protocol
Sponsored by: TrialCard

Patient Outcomes: How Do You Make Them Complement Your Brand’s POA?
Sponsored by: TrialCard

Bringing it all Together —  Two Minutes with Ken Faulkner
Provided by: PAREXEL Consulting

Bringing it all Together — Two Minutes with Ron Kraus
Provided by: PAREXEL Consulting

Editor’s Take Videos
Mark Engelhart
Chief Commercial Officer
ACM Global Central Laboratory

Julie Ross
Executive Vice President, CRO
Advanced Clinical

David Laky
General Manager, Clinical

Brian Schaechter
Senior Director, Clinical Trials Division
Marc Sirockman
Executive VP & General Manager
Artcraft Health

Bonnie A. Brescia
Founding Principal and 
BBK Worldwide
Christel Marchand Aprigliano
VP, Research Engagement
The Diabetes Collective

Bonnie A. Brescia
Founding Principal and 
BBK Worldwide

Claire Meunier
VP, Research Engagement
Michael J. Fox Foundation

Dr. J. Fredrick Pritchard
VP, Global Drug Development
Dr. Deborah Chee

Dr. Jim Eisenhart
Chiltern International Inc.

Joseph Sgherza
Senior VP Global Operations

Larry Florin
Clinical Leader, Life Sciences R&D Practice

Jim Nichols
VP, US Operations & Life Sciences

Dr. Jeffrey Kasher
Advisory Board Chairman

Abhishek Shankar
VP & Head, Life Sciences, North America
HCL Technologies

Dr. Margaret Hurley
President & CEO
Hurley Consulting Associates Ltd.

Dr. Ira Spector
Executive VP, Analytics & Consulting

David Burnham
VP, Strategic Alliance Management
INC Research

Andrew Townshend
Senior VP, Alliance Development
INC Research

Gregory Skalicky
Chief Commercial Officer
inVentiv Health Clinical

Mark Lanfear
Global Practice Lead — Life Science Solutions
Kelly Outsourcing and Consulting

Kara Dennis
Managing Director, Mobile Health

Michelle Petersen
Clinical Trial Manager

Bill Cooney
President & CEO
Medpoint Digital

Zaher El-Assi
Merge eClinical

Bill Gwinn
VP, Clinical Informatics Solutions

Ben McGraw
Strategic Marketing — Informatics
Mark Cziraky
VP, Research

Michael Pollock
VP, Real-world Outcome

Kent Thoelke
Executive VP, Scientific and Medical Affairs, Safety and Commercialization Services
PRA Health Sciences

Dr. Jamie Powers
Principal Consultant
SAS Health & Life Science

Lynn King
Senior Director, Clinical Monitoring
TKL Research

Dr. Sandra Lottes
VP, Global Clinical Development & Operations
United BioSource Corp.

Kathryn King
VP, Vault Clinical

Dr. Donald Deieso
Chairman and CEO
WIRB-Copernicus Group

Peter Benton
President & Chief Operating Officer
Worldwide Clinical Trials

2015 PharmaVOICE 100 Videos:

Steven Michaelson
Calcium USA

Patrick Hughes

Dr. Jules Mitchel
Target Health Inc.

Kara Dennis

Thomas Wicks
TrialScope Inc.

Dr. Sandra R. Lottes
United BioSource Corp.

Posted in:

Post a Comment

You must be logged in to post a Comment.